陈蓓迪;赵丽丹;张烜;
CHEN Bei-di;ZHAO Li-dan;ZHANG Xuan;Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases,Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院风湿免疫科国家皮肤与免疫疾病临床医学研究中心风湿免疫病学教育部重点实验室临床免疫中心

摘要(Abstract)：

系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种以慢性炎症和多器官损害为特征的自身免疫性疾病,主要累及育龄期女性,目前尚无法根治。SLE病因不明,发病风险与遗传及环境因素相关。近年来研究表明,SLE患者存在肠道菌群组成和功能紊乱,继而可引起肠道屏障功能破坏、慢性炎症和自身免疫激活,这可能是SLE发生发展的重要机制。本文对这一领域的相关研究进展予以概述,探讨菌群干预作为SLE防治新策略的潜在应用价值,并对未来SLE相关肠道菌群研究的发展方向进行展望。
Systemic lupus erythematosus(SLE) is a common autoimmune disease characterized by chronic inflammation and multi-organ damage and mainly affects women of childbearing age. SLE can only be controlled but not cured currently. The occurrence and development of SLE were reported to be associated with genetic factors as well as environmental triggers. In recent years, mounting evidence showed that there were compositional and functional changes in the gut microbiota of SLE patients. Also, the disturbed gut microbiota was suggested to partake in SLE pathogenesis by damaging the gut barrier, as well as inducing or aggravating chronic inflammation and autoimmunity. This review summarized the progress of research on the gut microbiota in SLE, discussed the clinical value of gut microbiota-related interventions, and envisions the future direction of research related to gut microbiota in lupus.

关键词(KeyWords)： 系统性红斑狼疮;肠道菌群;发病机制;菌群干预
systemic lupus erythematosus;gut microbiota;pathogenesis;microbiota-related intervention

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81788101、81630044);; 中国医学科学院医学与健康科技创新工程(2017-12M-1-008、2017-I2M-3-011、2016-12M-1-003、2016-12M-1-008)

作者(Authors): 陈蓓迪;赵丽丹;张烜;
CHEN Bei-di;ZHAO Li-dan;ZHANG Xuan;Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases,Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

参考文献(References)：

• [1] Van de Wiele T,Van Praet JT,Marzorati M,et al.How the microbiota shapes rheumatic diseases[J].Nat Rev Rheumatol,2016,12:398- 411.
• [2] Qin J,Li R,Raes J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464:59- 65.
• [3] Sethi V,Vitiello GA,Saxena D,et al.The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy[J].Gastroenterology,2019,156:2097- 2115.e2.
• [4] Stiemsma LT,Reynolds LA,Turvey SE,et al.The hygiene hypothesis:current perspectives and future therapies[J].Immunotargets Ther,2015,4:143- 157.
• [5] Skelly AN,Sato Y,Kearney S,et al.Mining the microbiota for microbial and metabolite-based immunotherapies[J].Nat Rev Immunol,2019,19:305- 323.
• [6] Atarashi K,Tanoue T,Ando M,et al.Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells[J].Cell,2015,163:367- 380.
• [7] Atarashi K,Tanoue T,Oshima K,et al.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota[J].Nature,2013,500:232- 236.
• [8] Hevia A,Milani C,Lopez P,et al.Intestinal dysbiosis associated with systemic lupus erythematosus[J].mBio,2014,5:e01548- 14.
• [9] He Z,Shao T,Li H,et al.Alterations of the gut micro-biome in Chinese patients with systemic lupus erythematosus[J].Gut Pathog,2016,8:64.
• [10] Li Y,Wang HF,Li X,et al.Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus[J].Clin Sci (Lond),2019,133:821- 838.
• [11] van der Meulen TA,Harmsen HJM,Vila AV,et al.Shared gut,but distinct oral microbiota composition in primary Sjogren's syndrome and systemic lupus erythematosus[J].J Autoimmun,2019,97:77- 87.
• [12] Chen B,Jia X,Xu J,et al.Proinflammatory and autoimmunogenic gut microbiome in systemic lupus erythematosus [OL].BioRxiv,2019.https://www.biorxiv.org/content/10.1101/621995v1.
• [13] Azzouz D,Omarbekova A,Heguy A,et al.Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal[J].Ann Rheum Dis,2019,78:947- 956.
• [14] Lloyd-Price J,Arze C,Ananthakrishnan AN,et al.Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J].Nature,2019,569:655- 662.
• [15] Breban M,Tap J,Leboime A,et al.Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J].Ann Rheum Dis,2017,76:1614- 1622.
• [16] Asquith M,Sternes PR,Costello ME,et al.HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome[J].Arthritis Rheumatol,2019,71:1642- 1650.
• [17] Unni KK,Holley KE,McDuffie FC,et al.Comparative study of NZB mice under germfree and conventional conditions[J].J Rheumatol,1975,2:36- 44.
• [18] Manfredo Vieira S,Hiltensperger M,Kumar V,et al.Translocation of a gut pathobiont drives autoimmunity in mice and humans[J].Science,2018,359:1156- 1161.
• [19] Ma Y,Xu X,Li M,et al.Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus[J].Mol Med,2019,25:35.
• [20] Fasano A.Leaky gut and autoimmune diseases[J].Clin Rev Allergy Immunol,2012,42:71- 78.
• [21] Ogunrinde E,Zhou Z,Luo Z,et al.A Link Between Plasma Microbial Translocation,Microbiome,and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients[J].Arthritis Rheumatol,2019,71:1858- 1868.
• [22] Zegarra-Ruiz DF,El Beidaq A,Iniguez AJ,et al.A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity[J].Cell Host Microbe,2019,25:113- 127.e6.
• [23] Schmidt TS,Hayward MR,Coelho LP,et al.Extensive transmission of microbes along the gastrointestinal tract[J].Elife,2019,8.pii:e42693.
• [24] Correa JD,Calderaro DC,Ferreira GA,et al.Subgingival microbiota dysbiosis in systemic lupus erythematosus:association with periodontal status[J].Microbiome,2017,5:34.
• [25] 焦禹豪,陈蓓迪,张烜.肠道菌群在天然免疫系统中的作用[J].协和医学杂志,2019,10:257- 262.
• [26] Lopez P,de Paz B,Rodriguez-Carrio J,et al.Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients[J].Sci Rep,2016,6:24072.
• [27] Mu Q,Cabana-Puig X,Mao J,et al.Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota[J].Microbiome,2019,7:105.
• [28] Ansaldo E,Slayden LC,Ching KL,et al.Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis[J].Science,2019,364:1179- 1184.
• [29] Li ZX,Zeng S,Wu HX,et al.The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection:a systematic review and meta-analysis[J].Clin Exp Med,2019,19:23- 36.
• [30] Ruff WE,Dehner C,Kim WJ,et al.Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity[J].Cell Host Microbe,2019,26:100- 113.e8.
• [31] Greiling TM,Dehner C,Chen X,et al.Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus[J].Sci Transl Med,2018,10.pii:eaan2306.
• [32] Edwards MR,Dai R,Heid B,et al.Commercial rodent diets differentially regulate autoimmune glomerulonephritis,epigenetics and microbiota in MRL/lpr mice[J].Int Immunol,2017,29:263- 276.
• [33] Gill PA,van Zelm MC,Muir JG,et al.Review article:short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders[J].Aliment Pharmacol Ther,2018,48:15- 34.
• [34] White CA,Pone EJ,Lam T,et al.Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp- 1 expression for epigenetic modulation of antibody and autoantibody responses[J].J Immunol,2014,193:5933- 5950.
• [35] Tzang BS,Liu CH,Hsu KC,et al.Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice[J].Br J Nutr,2017,118:333- 342.
• [36] Hsu TC,Huang CY,Liu CH,et al.Lactobacillus paracasei GMNL- 32,Lactobacillus reuteri GMNL- 89 and L.reuteri GMNL- 263 ameliorate hepatic injuries in lupus-prone mice[J].Br J Nutr,2017,117:1066- 1074.
• [37] Mu Q,Zhang H,Liao X,et al.Control of lupus nephritis by changes of gut microbiota[J].Microbiome,2017,5:73.
• [38] Toral M,Robles-Vera I,Romero M,et al.Lactobacillus fermentum CECT5716:a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus[J].FASEB J,2019,33:10005- 10018.
• [39] Allegretti JR,Mullish BH,Kelly C,et al.The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications[J].Lancet,2019,394:420- 431.
• [40] 张发明,李玥.粪菌移植治疗炎症性肠病的争议[J].协和医学杂志,2019,10:211- 215.